Epoprostenol/sildenafilLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1943卷 / 1期

关键词：

D O I：

10.1007/s40278-023-33192-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：307 / 307

相关论文

共 50 条

[41] Epoprostenol/milrinone/nitric-oxideLack of efficacy: case report
Reactions Weekly, 2023, 1949 (1) : 208 - 208
[42] SildenafilLack of efficacy
Reactions Weekly, 2024, 2014 (1) : 611 - 611
[43] Macitentan/SildenafilLack of efficacy
Reactions Weekly, 2024, 2016 (1) : 268 - 268
[44] SildenafilLack of efficacy
Reactions Weekly, 2024, 2005 (1) : 737 - 737
[45] SildenafilLack of efficacy
Reactions Weekly, 2024, 2001 (1) : 314 - 314
[46] Endothelin-receptor-antagonists/Nitric-oxide/SildenafilLack of efficacy: case report
Reactions Weekly, 2025, 2042 (1) : 178 - 178
[47] Ambrisentan/sildenafilLack of efficacy
Reactions Weekly, 2024, 2007 (1) : 31 - 31
[48] Bosentan/epoprostenol/treprostinilHepatotoxicity, infusion site reactions and lack of efficacy: case report
Reactions Weekly, 2021, 1886 (1) : 102 - 102
[49] Epoprostenol/sildenafilPsychiatric symptoms: case report
Reactions Weekly, 2012, 1385 (1) : 18 - 18
[50] Epoprostenol/treprostinilNo response: case report
Reactions Weekly, 2023, 1939 (1) : 203 - 203

← 1 2 3 4 5 →